Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., May 3, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. , a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and...